83 results
424B3
PRTG
Portage Biotech Inc
6 Mar 24
Prospectus supplement
9:36pm
scientific oversight Lean structure with financial flexibility Preferred Partner for Pharma in I/O Deep industry network facilitates engagement with big
6-K
EX-99.1
PRTG
Portage Biotech Inc
6 Mar 24
Current report (foreign)
9:11pm
Preferred Partner for Pharma in I/O Deep industry network facilitates engagement with big pharma and biotech Packaged for commercialization
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
deducting placement agent’s fees and estimated offering expenses of approximately $0.7 million.
Pursuant to an engagement letter, dated as of August 26 … to an engagement letter, dated as of August 26, 2023, between the Company and the “Placement Agent, the Company paid the Placement Agent a total cash fee equal
6-K
EX-99.1
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
to an engagement letter, dated as of August 26, 2023, between the Company and H.C. Wainwright & Co., LLC (the “Placement Agent”), the Company paid … offering expenses.
Pursuant to an engagement letter, dated as of August 26, 2023, between the Company and the “Placement Agent, the Company paid
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
of extracellular adenosine. Engagement with adenosine receptors type 2A (“A2A”) and type 2B (“A2B”) triggers a dampening effect on the immune … deducting placement agent’s fees and estimated offering expenses.
Pursuant to an engagement letter, dated as of August 26, 2023, between us and H.C
424B3
i8baht8jab1hx5v yzyl
18 Jan 24
Prospectus supplement
5:41pm
6-K
EX-99.1
6enbo05gfbwrk wa5t69
18 Jan 24
Current report (foreign)
5:09pm
424B3
w4u t479iwaaknkf
28 Nov 23
Prospectus supplement
4:03pm
6-K
EX-99.1
7t32jzwzrqtg
28 Nov 23
Current report (foreign)
4:01pm
6-K
EX-99.2
n3dlumqkczyvk6xf4
28 Nov 23
Current report (foreign)
4:01pm
424B3
gkr3r
14 Nov 23
Prospectus supplement
6:00am
6-K
EX-99.1
m356s1ba0wpcik8
13 Nov 23
Current report (foreign)
6:10am
424B3
vnkxc4cydgcjp a9
7 Nov 23
Prospectus supplement
4:50pm
F-1
tqaxng54
31 Oct 23
Registration statement (foreign)
4:05pm
F-1
EX-5.1
h7lezphcuify
31 Oct 23
Registration statement (foreign)
4:05pm
6-K
6b04mdc 8n18azziw
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.5
bri1qn
3 Oct 23
Current report (foreign)
4:05pm
424B5
7613 jyk07
2 Oct 23
Prospectus supplement for primary offering
6:01pm
6-K
EX-99.1
tnh95jed ock
8 Sep 23
Current report (foreign)
4:01pm
6-K
EX-99.2
8a26pa
29 Aug 23
Current report (foreign)
4:01pm